Nicole Onetto

CIK: 0001220049

Transaction Breakdown

Open Market Buys (P)0 (0.0%)

High conviction signal

Open Market Sales (S)0 (0.0%)

Position reduction

Option Exercises (M)0 (0.0%)

Derivative conversions

Awards (A)9 (56.3%)

Compensation grants

Other (G, F, J, C, D, …)7 (43.8%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (1)

BOLT

Bolt Biotherapeutics, Inc.

Director

Discretionary Trading P&L

Holdings

Transaction History (16 total)

BOLT
Bolt Biotherapeutics, Inc.
Jun 10, 2026
Award(A)
Stock Option (Right to Buy)
Direct
5K shares-
BOLT
Bolt Biotherapeutics, Inc.
Dec 12, 2025
Award(A)
Director Stock Option (Right to Buy)
Direct
1.4K shares-
BOLT
Bolt Biotherapeutics, Inc.
Dec 12, 2025
Disposition(D)
Director Stock Option (Right to Buy)
Direct
1.4K shares-
BOLT
Bolt Biotherapeutics, Inc.
Dec 12, 2025
Award(A)
Director Stock Option (Right to Buy)
Direct
1.1K shares-
BOLT
Bolt Biotherapeutics, Inc.
Dec 12, 2025
Disposition(D)
Director Stock Option (Right to Buy)
Direct
1.1K shares-
BOLT
Bolt Biotherapeutics, Inc.
Dec 12, 2025
Award(A)
Director Stock Option (Right to Buy)
Direct
611 shares-
BOLT
Bolt Biotherapeutics, Inc.
Dec 12, 2025
Disposition(D)
Director Stock Option (Right to Buy)
Direct
611 shares-
BOLT
Bolt Biotherapeutics, Inc.
Dec 12, 2025
Award(A)
Director Stock Option (Right to Buy)
Direct
1.3K shares-
BOLT
Bolt Biotherapeutics, Inc.
Dec 12, 2025
Disposition(D)
Director Stock Option (Right to Buy)
Direct
1.3K shares-
BOLT
Bolt Biotherapeutics, Inc.
Dec 12, 2025
Award(A)
Director Stock Option (Right to Buy)
Direct
1.3K shares-
BOLT
Bolt Biotherapeutics, Inc.
Dec 12, 2025
Disposition(D)
Director Stock Option (Right to Buy)
Direct
1.3K shares-
BOLT
Bolt Biotherapeutics, Inc.
Dec 12, 2025
Award(A)
Director Stock Option (Right to Buy)
Direct
1.1K shares-
BOLT
Bolt Biotherapeutics, Inc.
Dec 12, 2025
Disposition(D)
Director Stock Option (Right to Buy)
Direct
1.1K shares-
BOLT
Bolt Biotherapeutics, Inc.
Dec 12, 2025
Award(A)
Director Stock Option (Right to Buy)
Direct
1.1K shares-
BOLT
Bolt Biotherapeutics, Inc.
Dec 12, 2025
Disposition(D)
Director Stock Option (Right to Buy)
Direct
1.1K shares-
BOLT
Bolt Biotherapeutics, Inc.
May 27, 2025
Award(A)
Stock Option (Right to Buy)
Direct
1.1K shares-

		Type	Shares	Price		Ownership
Jun 10, 2026	BOLT Bolt Biotherapeutics, Inc.	Award(A) Stock Option (Right to Buy)	5,000	-	-	Direct
Dec 12, 2025	BOLT Bolt Biotherapeutics, Inc.	Award(A) Director Stock Option (Right to Buy)	1,393	-	-	Direct
Dec 12, 2025	BOLT Bolt Biotherapeutics, Inc.	Disposition(D) Director Stock Option (Right to Buy)	1,393	-	-	Direct
Dec 12, 2025	BOLT Bolt Biotherapeutics, Inc.	Award(A) Director Stock Option (Right to Buy)	1,107	-	-	Direct
Dec 12, 2025	BOLT Bolt Biotherapeutics, Inc.	Disposition(D) Director Stock Option (Right to Buy)	1,107	-	-	Direct
Dec 12, 2025	BOLT Bolt Biotherapeutics, Inc.	Award(A) Director Stock Option (Right to Buy)	611	-	-	Direct
Dec 12, 2025	BOLT Bolt Biotherapeutics, Inc.	Disposition(D) Director Stock Option (Right to Buy)	611	-	-	Direct
Dec 12, 2025	BOLT Bolt Biotherapeutics, Inc.	Award(A) Director Stock Option (Right to Buy)	1,250	-	-	Direct
Dec 12, 2025	BOLT Bolt Biotherapeutics, Inc.	Disposition(D) Director Stock Option (Right to Buy)	1,250	-	-	Direct
Dec 12, 2025	BOLT Bolt Biotherapeutics, Inc.	Award(A) Director Stock Option (Right to Buy)	1,250	-	-	Direct
Dec 12, 2025	BOLT Bolt Biotherapeutics, Inc.	Disposition(D) Director Stock Option (Right to Buy)	1,250	-	-	Direct
Dec 12, 2025	BOLT Bolt Biotherapeutics, Inc.	Award(A) Director Stock Option (Right to Buy)	1,100	-	-	Direct
Dec 12, 2025	BOLT Bolt Biotherapeutics, Inc.	Disposition(D) Director Stock Option (Right to Buy)	1,100	-	-	Direct
Dec 12, 2025	BOLT Bolt Biotherapeutics, Inc.	Award(A) Director Stock Option (Right to Buy)	1,100	-	-	Direct
Dec 12, 2025	BOLT Bolt Biotherapeutics, Inc.	Disposition(D) Director Stock Option (Right to Buy)	1,100	-	-	Direct
May 27, 2025	BOLT Bolt Biotherapeutics, Inc.	Award(A) Stock Option (Right to Buy)	1,100	-	-	Direct

1-16 of 16 transactions

About ONETTO NICOLE

ONETTO NICOLE (SEC CIK 0001220049) files insider reports with the SEC as Director of Bolt Biotherapeutics, Inc. (BOLT).

Signal8 holds 3 ownership filings by ONETTO NICOLE, all Form 4s, filed between Jul 2, 2025 and Jun 11, 2026. Those filings report 16 transactions, from May 27, 2025 to Jun 10, 2026. Signal8's Form 4 history starts in Sep 2024.

The business address on ONETTO NICOLE's filings is in REDWOOD CITY, CA.

Recent filings by ONETTO NICOLE

Jun 10, 2026: Grant or award of BOLT derivative securities (Form 4, code A).
Dec 12, 2025: Grant or award of BOLT derivative securities (Form 4, code A).
Dec 12, 2025: Disposition to issuer transaction of BOLT derivative securities (Form 4, code D).
Dec 12, 2025: Grant or award of BOLT derivative securities (Form 4, code A).
Dec 12, 2025: Disposition to issuer transaction of BOLT derivative securities (Form 4, code D).

Other insiders filing for Bolt Biotherapeutics, Inc. (BOLT)

GUJRATHI SHEILA, Chief Strategy Officer
Yonehiro Grant, Chief Operating Officer
Nemec Sarah, Senior VP, Finance and PAO
Quinn William P., President, CEO and CFO
Berner Laura, Director
LAPORTE KATHLEEN, Director

How to read Form 4 transaction codes